Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Keratoconjunctivitis Sicca, in Sjogren's Syndrome”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT03983408
What this trial is testing

Impact of Korean Red Ginseng on Fatigue in Patients With Rheumatic Disease

Who this might be right for
Sjögren's SyndromeRheumatic DiseasesKorean Red Ginseng
Hanyang University 120
Testing effectiveness (Phase 2)Study completedNCT00363350
What this trial is testing

Rituximab Treatment in Sjogren's Syndrome

Who this might be right for
Sjogren's Syndrome
University Medical Center Groningen 30
Early research (Phase 1)Study completedNCT00101829
What this trial is testing

Anti-CD20 Antibody Therapy for Sjogren's Syndrome

Who this might be right for
Sjogren's Syndrome
National Institute of Allergy and Infectious Diseases (NIAID) 12
Post-approval studies (Phase 4)Looking for participantsNCT04981145
What this trial is testing

The Efficacy and Safety of Iguratimod (IGU) in the Treatment of Primary Sjögren's Syndrome

Who this might be right for
Primary Sjögren's Syndrome
Second Affiliated Hospital, Zhejiang University, School of Medicine 78
Testing effectiveness (Phase 2)Study completedNCT01393132
What this trial is testing

Comparative Study of Thymosin Beta 4 Eye Drops vs. Vehicle in the Treatment of Severe Dry Eye

Who this might be right for
Dry EyeSjogren's SyndromeGraft vs. Host Disease
Michigan Cornea Consultants, PC 9
Large-scale testing (Phase 3)Not Yet RecruitingNCT07791199
What this trial is testing

Continued Access to Deucravacitinib for Adult SLE/SjD and Pediatric PsO/PsA Study Completers

Who this might be right for
Systemic Lupus ErythematosusSjögren's DiseasePsoriasis+1 more
Bristol-Myers Squibb 2,300
Large-scale testing (Phase 3)Looking for participantsNCT07621809
What this trial is testing

Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom Burden

Who this might be right for
Sjögren´s Disease
Novartis Pharmaceuticals 570
Testing effectiveness (Phase 2)Ended earlyNCT01316770
What this trial is testing

Dexamethasone Irrigation of the Parotid Glands in Primary Sjögren's Syndrome Subjects

Who this might be right for
Sjögren's SyndromeXerostomia
National Institute of Dental and Craniofacial Research (NIDCR) 14
Testing effectiveness (Phase 2)Study completedNCT04572841
What this trial is testing

Safety, Tolerability, Pharmacokinetics, and Therapeutic Efficacy of SAR441344 in Primary Sjögren's Syndrome (pSjS)

Who this might be right for
Sjögren's SyndromeSjogren's Syndrome
Sanofi 84
Testing effectiveness (Phase 2)UnknownNCT05383677
What this trial is testing

Anifrolumab Treatment for 24 Weeks in Patients With Primary Sjögren's Syndrome

Who this might be right for
Sjogren's Syndrome
University Medical Center Groningen 30
Large-scale testing (Phase 3)UnknownNCT05694130
What this trial is testing

Tacrolimus Plus Glucocorticoid for Severe Thrombocytopenia in SS

Who this might be right for
Sjogren Syndrome With Other Organ Involvement
Peking Union Medical College Hospital 110
Large-scale testing (Phase 3)Study completedNCT06104124
What this trial is testing

Evaluate the Efficacy and Safety of Dazodalibep in Participants With Sjögren's Syndrome (SS) With Moderate-to-severe Systemic Disease Activity

Who this might be right for
Sjogren's Syndrome
Amgen 651
Early research (Phase 1)Study completedNCT03817424
What this trial is testing

Evaluate VIB7734 in Participants With Systemic Lupus Erythematosus (SLE), Cutaneous Lupus Erythematosus (CLE), Sjogren's Syndrome, Systemic Sclerosis, Polymyositis, and Dermatomyositis

Who this might be right for
Systemic Lupus ErythematosusCutaneous Lupus ErythematosusSjogren's Syndrome+3 more
Amgen 31
Testing effectiveness (Phase 2)Ended earlyNCT04700280
What this trial is testing

A Study Evaluating the Effects of GLPG3970 Given as an Oral Treatment for 12 Weeks in Adults With Active Primary Sjögren's Syndrome (pSS)

Who this might be right for
Primary Sjögren Syndrome
Lakefront Biotherapeutics NV 31
Early research (Phase 1)Study completedNCT01716312
What this trial is testing

Omalizumab for Lupus

Who this might be right for
Systemic Lupus ErthematosusSjogren's Syndrome
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) 17
Not applicableEnded earlyNCT06364657
What this trial is testing

Differences in Corneal Structure and Function in Patients With Sjogrens vs. Non-Sjogrens Dry Eye

Who this might be right for
Sjogren's SyndromeDry EyeNeurotrophic Keratitis
Johns Hopkins University 13
Not applicableUnknownNCT04749875
What this trial is testing

Study of Leukocyte Populations in Patients With Chronic Inflammatory

Who this might be right for
Systemic Autoimmune DiseaseChronic Inflammatory RheumatismSjogren's Syndrome+3 more
Assistance Publique - Hôpitaux de Paris 1,500
Not applicableStudy completedNCT03757065
What this trial is testing

Cell Surface Marker Expression in Autoimmune Diseases

Who this might be right for
Systemic Lupus ErythematosusSjogren's SyndromeMultiple Sclerosis+4 more
Alpine Immune Sciences, Inc. 14
Very early researchUnknownNCT06417398
What this trial is testing

Preliminary Clinical Study of UTAA09 Injection in the Treatment of Relapsed/Refractory Autoimmune Diseases

Who this might be right for
Systemic Lupus ErythematosusIdiopathic Inflammatory MyopathiesSystemic Sclerosis+4 more
PersonGen BioTherapeutics (Suzhou) Co., Ltd. 10
Testing effectiveness (Phase 2)Study completedNCT03247686
What this trial is testing

RSLV-132 in Subjects With Primary Sjogren's Syndrome

Who this might be right for
Sjogren's Syndrome
Resolve Therapeutics 28
Next Page